Global Nanoparticles - Metal & Metal Oxides Report Thumbnail

Global Nanoparticles - Metal & Metal Oxides Market by Type (Alumina, Iron Oxide, Gold, Silver, Cerium, Gadolinium), by Application (In-vitro assays, Targeted Drug Delivery, In-vivo Imaging, Proton Therapy) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

  • Report ID: PH-75506
  • Author: Up Market Research
  • Rating: 4.7
  • Total Reviews: 92
  • No. Of Pages: 220
  • Format:
  • Pub. Date: 2021-10-21
  • Share:

Industry Insights

In 2016, the global market for nanoparticles-metal & metal oxides in healthcare was valued at USD 25.86 million. One of the main factors for the estimated revenue is the presence of a significant number of metal nanoparticle based drugs that have been approved by the U.S. FDA. There are also a lot of products that are in the clinical and investigational stages of development, which will increase the industrial appeal of this field.

These particles are versatile and can be used in many biomedical applications, including radiotherapy enhancement, thermal ablation, radiotherapy enhancement, high sensitive diagnostic assays and drug & Gene delivery. In the future, technological advancements that reduce adverse events related to the use of these products will influence the pace of progress.

U.S. market for nanoparticles & metal oxides in healthcare, according to application, 2013-2025 (USD billion)

Scientists and biologists are currently conducting research to improve our understanding of metallic nanoparticles to decrease the toxic effects. These developments will likely lead to an increase in the production and sales of these molecules over the forecast period.

The pharmaceutical industry is a dynamic marketplace that changes with rising manufacturing costs, evolving regulatory standards and a growing need for effective, sophisticated health solutions. These factors are continually putting pressure on pharmaceutical producers to fulfill the untapped market demand. Because of these factors, nanoparticle technology is a source of high-quality revenue generation. They have significant potential to aid in disease management.

Market growth will be driven by the presence of many projects in R&D. This will increase the market's future product offerings. The high potential for revenue in this market is further bolstered by the existence of government-backed programs like the National Nanotechnology Initiative (NNI), which was launched in 2000 and provides support for advance R&D projects related to nanomedicine development.

Type Insights

Due to their widespread adoption in therapeutic development, gold nanoparticles accounted for the largest percentage. This steady increase in gold nanoparticle adoption is due to factors such as greater compatibility, low toxicity & tunable stability, small dimensions, and better compatibility.

Moreover, gold nanocages coated with the temperature-sensitive polymer are applicable in targeted drug delivery that on interaction with near-infrared radiations, release effectors. These effectors can be used to monitor drug interactions and provide efficient control. This is why they are becoming increasingly popular in imaging, disease monitoring and drug delivery applications.

Alumina-based molecules will continue to grow because of the growing interest in its therapeutic uses for targeted cell destruction. Because of its high porosity, aluminum oxide is being used in combination with polymeric membranes to enhance drug delivery.

Application Insights

In-vivo imaging accounts for the largest revenue share. This is due to increasing use of nanoshells like Au3Cu1 which are reported to increase contrast for blood vessels in order to be used for in vivo MR angiography. AuNPs can also be used as probes to enable both in-vivo and in-vitro visual monitoring for protease activity.

Targeted delivery will show the highest YoY growth due to ongoing research into drug delivery applications using nanotechnology. The development of photo-modulated nanoshells to deliver drugs is expected to increase the technology's adoption.

Market for nanoparticles in the metal & oxides market in healthcare by region, 2016, (%)

Regional Insights

North America was the country with the highest revenue share in 2016, thanks to the existence of strong regulatory guidelines for therapeutic development in the region. The region is seeing inter-country cooperation in the production and use of nanoparticles. The Regulatory Cooperation Council (RCC) was one example of how the U.S., Canada and other countries collaborated in nanomaterials research. In January 2014, Washington DC hosted a conference to finalize the regional nanotechnology work plan.

Asia Pacific will see the most rapid growth due to increased investment in nanoparticle production and increase in clinical studies to determine the toxicity of nanoparticles. The potential nanotechnology hubs in the near future have been identified as Asian countries. This has led to an increase in research on nanomolecules.

Competitive Insights

Pfizer Inc., Nanobiotix, nanoComposix, AstraZeneca, Merck KGaA, Immunolight LLC, Nanospectra Biosciences, Inc, Brigham, and Women's Hospital(BWH) are some of the major players in this market. The pharma-biotech market requires large capital investments and is highly research-intensive in nature. For their detection and characterisation, market entities work to develop more advanced analysis tools.

The global market for nanoparticles is expected to be driven by product innovations in human therapeutics, and growing global demand for strong disease treatment solutions. The presence of many products in development and a large number opportunistic clinical trials will further boost revenue. Nano biotechnology has attracted large amounts of R&D investment for nanoparticle-based drugs & chemotherapeutic agents.

The Report Covers Certain Segments

This report provides a forecast of revenue growth at the country and regional level, and an analysis on the most recent trends and opportunities in each sub-segment from 2013 through 2025. Up Market Research has divided the Nanoparticles-metal & Metal Oxides market in Healthcare on the basis type, application, region, and purpose.

  • Type Outlook (Revenue, USD Billion; 2013 - 2025)

    • Nanoparticles of Gold

    • Silver Nanoparticles

    • Iron Oxide Nanoparticles

    • Alumina Nanoparticles

    • Gadolinium Oxide Nanoparticles

    • Other

  • Application Outlook (Revenue, USD Billion; 2013 - 2025)

    • In-vivo Imaging

    • Targeted drug delivery

    • Proton Therapy

    • In-vitro Assays

    • Cell & Phantom Imaging

  • Regional Outlook (Revenue USD Billion; 2013-2025)

    • North America

      • The U.S.

      • Canada

    • Europe

      • Germany

      • UK

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

    • Middle East and Africa (MEA).

      • South Africa

These are the most frequently asked questions about this report

b. Global market for nanoparticles metals and metal oxides was valued at USD 36.07 Billion in 2019, and is forecast to grow to USD 40.73 Billion by 2020.

b. Global nanoparticles metals and metal oxides markets are expected to grow at a compound annual rate of 13.78% between 2018-2025, to reach USD 80.74 trillion by 2025.

b. With a 41.5% share in 2019, North America was the dominant market for nanoparticles metals and metal oxides. This can be attributed to the existence of effective regulatory guidelines in North America regarding therapeutic development and collaboration between countries for the production nanoparticles.

b. Pfizer Inc., Nanobiotix, nanoComposix, AstraZeneca, Merck KGaA, Immunolight LLC, Nanospectra Biosciences, Inc, Brigham and Women's Hospital, (BWH) are some of the key players in the telemedicine marketplace.

b. The market growth is driven by the presence of many metal nanoparticle-based medicines, their versatility, and technological advances.

Up Market Research published a new report titled “Nanoparticles - Metal & Metal Oxides Market research report which is segmented by Type (Alumina, Iron Oxide, Gold, Silver, Cerium, Gadolinium), by Application (In-vitro assays, Targeted Drug Delivery, In-vivo Imaging, Proton Therapy), By Players/Companies Nanobiotix, nanoComposix, Inc, Merck KGaA, Nanospectra Biosciences, Brigham, Immunolight LLC, AstraZeneca, Women's Hospital (BWH) Pharma-biotech market involves huge capital investment and is research intensive in nature Market entities are engaged in the development of more sophisticated analysis tools for their detection and characterization, Pfizer Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.


Report Scope

Report AttributesReport Details
Report TitleNanoparticles - Metal & Metal Oxides Market Research Report
By TypeAlumina, Iron Oxide, Gold, Silver, Cerium, Gadolinium
By ApplicationIn-vitro assays, Targeted Drug Delivery, In-vivo Imaging, Proton Therapy
By CompaniesNanobiotix, nanoComposix, Inc, Merck KGaA, Nanospectra Biosciences, Brigham, Immunolight LLC, AstraZeneca, Women's Hospital (BWH) Pharma-biotech market involves huge capital investment and is research intensive in nature Market entities are engaged in the development of more sophisticated analysis tools for their detection and characterization, Pfizer Inc
Regions CoveredNorth America, Europe, APAC, Latin America, MEA
Base Year2020
Historical Year2018 to 2019 (Data from 2010 can be provided as per availability)
Forecast Year2028
Number of Pages220
Number of Tables & Figures154
Customization AvailableYes, the report can be customized as per your need.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.


Global Nanoparticles - Metal   Metal Oxides Industry Outlook

Global Nanoparticles - Metal & Metal Oxides Market Report Segments:

The market is segmented by Type (Alumina, Iron Oxide, Gold, Silver, Cerium, Gadolinium), by Application (In-vitro assays, Targeted Drug Delivery, In-vivo Imaging, Proton Therapy).

Nanoparticles - Metal & Metal Oxides Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.


Key Benefits for Industry Participants & Stakeholders:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Nanoparticles - Metal & Metal Oxides Market

Overview of the regional outlook of the Nanoparticles - Metal & Metal Oxides Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.


Nanoparticles - Metal   Metal Oxides Market Overview

Highlights of The Nanoparticles - Metal & Metal Oxides Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Nanoparticles - Metal & Metal Oxides Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
        6. By Type:

                1. Alumina

                2. Iron Oxide

                3. Gold

                4. Silver

                5. Cerium

                6. Gadolinium

        7. By Application:

                1. In-vitro assays

                2. Targeted Drug Delivery

                3. In-vivo Imaging

                4. Proton Therapy

  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Nanoparticles - Metal & Metal Oxides Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.


How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Nanoparticles - Metal   Metal Oxides Market Trends

Reasons to Purchase the Nanoparticles - Metal & Metal Oxides Market Report:

  • The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
  • Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
  • Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
  • The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
  • Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nanoparticles - Metal & Metal Oxides Market Overview
   4.1 Introduction 
      4.1.1 Market Taxonomy 
      4.1.2 Market Definition 
      4.1.3 Macro-Economic Factors Impacting the Market Growth 
   4.2 Nanoparticles - Metal & Metal Oxides Market Dynamics 
      4.2.1 Market Drivers 
      4.2.2 Market Restraints 
      4.2.3 Market Opportunity 
   4.3 Nanoparticles - Metal & Metal Oxides Market - Supply Chain Analysis 
      4.3.1 List of Key Suppliers 
      4.3.2 List of Key Distributors 
      4.3.3 List of Key Consumers 
   4.4 Key Forces Shaping the Nanoparticles - Metal & Metal Oxides Market 
      4.4.1 Bargaining Power of Suppliers 
      4.4.2 Bargaining Power of Buyers 
      4.4.3 Threat of Substitution 
      4.4.4 Threat of New Entrants 
      4.4.5 Competitive Rivalry 
   4.5 Global Nanoparticles - Metal & Metal Oxides Market Size & Forecast, 2018-2028 
      4.5.1 Nanoparticles - Metal & Metal Oxides Market Size and Y-o-Y Growth 
      4.5.2 Nanoparticles - Metal & Metal Oxides Market Absolute $ Opportunity 


Chapter 5 Global Nanoparticles - Metal & Metal Oxides Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Nanoparticles - Metal & Metal Oxides Market Size Forecast by Type
      5.2.1 Alumina
      5.2.2 Iron Oxide
      5.2.3 Gold
      5.2.4 Silver
      5.2.5 Cerium
      5.2.6 Gadolinium
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Nanoparticles - Metal & Metal Oxides Market Analysis and Forecast by Application
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Application
      6.1.2 Basis Point Share (BPS) Analysis by Application
      6.1.3 Absolute $ Opportunity Assessment by Application
   6.2 Nanoparticles - Metal & Metal Oxides Market Size Forecast by Application
      6.2.1 In-vitro assays
      6.2.2 Targeted Drug Delivery
      6.2.3 In-vivo Imaging
      6.2.4 Proton Therapy
   6.3 Market Attractiveness Analysis by Application

Chapter 7 Global Nanoparticles - Metal & Metal Oxides Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Nanoparticles - Metal & Metal Oxides Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Nanoparticles - Metal & Metal Oxides Analysis and Forecast
   9.1 Introduction
   9.2 North America Nanoparticles - Metal & Metal Oxides Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Nanoparticles - Metal & Metal Oxides Market Size Forecast by Type
      9.6.1 Alumina
      9.6.2 Iron Oxide
      9.6.3 Gold
      9.6.4 Silver
      9.6.5 Cerium
      9.6.6 Gadolinium
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Nanoparticles - Metal & Metal Oxides Market Size Forecast by Application
      9.10.1 In-vitro assays
      9.10.2 Targeted Drug Delivery
      9.10.3 In-vivo Imaging
      9.10.4 Proton Therapy
   9.11 Basis Point Share (BPS) Analysis by Application 
   9.12 Absolute $ Opportunity Assessment by Application 
   9.13 Market Attractiveness Analysis by Application

Chapter 10 Europe Nanoparticles - Metal & Metal Oxides Analysis and Forecast
   10.1 Introduction
   10.2 Europe Nanoparticles - Metal & Metal Oxides Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Nanoparticles - Metal & Metal Oxides Market Size Forecast by Type
      10.6.1 Alumina
      10.6.2 Iron Oxide
      10.6.3 Gold
      10.6.4 Silver
      10.6.5 Cerium
      10.6.6 Gadolinium
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Nanoparticles - Metal & Metal Oxides Market Size Forecast by Application
      10.10.1 In-vitro assays
      10.10.2 Targeted Drug Delivery
      10.10.3 In-vivo Imaging
      10.10.4 Proton Therapy
   10.11 Basis Point Share (BPS) Analysis by Application 
   10.12 Absolute $ Opportunity Assessment by Application 
   10.13 Market Attractiveness Analysis by Application

Chapter 11 Asia Pacific Nanoparticles - Metal & Metal Oxides Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Nanoparticles - Metal & Metal Oxides Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Nanoparticles - Metal & Metal Oxides Market Size Forecast by Type
      11.6.1 Alumina
      11.6.2 Iron Oxide
      11.6.3 Gold
      11.6.4 Silver
      11.6.5 Cerium
      11.6.6 Gadolinium
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Nanoparticles - Metal & Metal Oxides Market Size Forecast by Application
      11.10.1 In-vitro assays
      11.10.2 Targeted Drug Delivery
      11.10.3 In-vivo Imaging
      11.10.4 Proton Therapy
   11.11 Basis Point Share (BPS) Analysis by Application 
   11.12 Absolute $ Opportunity Assessment by Application 
   11.13 Market Attractiveness Analysis by Application

Chapter 12 Latin America Nanoparticles - Metal & Metal Oxides Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Nanoparticles - Metal & Metal Oxides Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Nanoparticles - Metal & Metal Oxides Market Size Forecast by Type
      12.6.1 Alumina
      12.6.2 Iron Oxide
      12.6.3 Gold
      12.6.4 Silver
      12.6.5 Cerium
      12.6.6 Gadolinium
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Nanoparticles - Metal & Metal Oxides Market Size Forecast by Application
      12.10.1 In-vitro assays
      12.10.2 Targeted Drug Delivery
      12.10.3 In-vivo Imaging
      12.10.4 Proton Therapy
   12.11 Basis Point Share (BPS) Analysis by Application 
   12.12 Absolute $ Opportunity Assessment by Application 
   12.13 Market Attractiveness Analysis by Application

Chapter 13 Middle East & Africa (MEA) Nanoparticles - Metal & Metal Oxides Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Nanoparticles - Metal & Metal Oxides Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Nanoparticles - Metal & Metal Oxides Market Size Forecast by Type
      13.6.1 Alumina
      13.6.2 Iron Oxide
      13.6.3 Gold
      13.6.4 Silver
      13.6.5 Cerium
      13.6.6 Gadolinium
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Nanoparticles - Metal & Metal Oxides Market Size Forecast by Application
      13.10.1 In-vitro assays
      13.10.2 Targeted Drug Delivery
      13.10.3 In-vivo Imaging
      13.10.4 Proton Therapy
   13.11 Basis Point Share (BPS) Analysis by Application 
   13.12 Absolute $ Opportunity Assessment by Application 
   13.13 Market Attractiveness Analysis by Application

Chapter 14 Competition Landscape 
   14.1 Nanoparticles - Metal & Metal Oxides Market: Competitive Dashboard
   14.2 Global Nanoparticles - Metal & Metal Oxides Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Nanobiotix
      14.3.2 nanoComposix
      14.3.3 Inc
      14.3.4 Merck KGaA
      14.3.5 Nanospectra Biosciences
      14.3.6 Brigham
      14.3.7 Immunolight LLC
      14.3.8 AstraZeneca
      14.3.9 Women's Hospital (BWH) Pharma-biotech market involves huge capital investment and is research intensive in nature Market entities are engaged in the development of more sophisticated analysis tools for their detection and characterization
      14.3.10 Pfizer Inc
Segments Covered in the Report
The global Nanoparticles - Metal & Metal Oxides market has been segmented based on

By Type
  • Alumina
  • Iron Oxide
  • Gold
  • Silver
  • Cerium
  • Gadolinium
By Application
  • In-vitro assays
  • Targeted Drug Delivery
  • In-vivo Imaging
  • Proton Therapy
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Nanobiotix
  • nanoComposix
  • Inc
  • Merck KGaA
  • Nanospectra Biosciences
  • Brigham
  • Immunolight LLC
  • AstraZeneca
  • Women's Hospital (BWH) Pharma-biotech market involves huge capital investment and is research intensive in nature Market entities are engaged in the development of more sophisticated analysis tools for their detection and characterization
  • Pfizer Inc

Buy Report